Today, we experienced problems with our IV calculations, and were not able to provide fund prices within deadline for the morning session. The issue was resolved shortly after 10 a.m. The reason for ...

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. The BSA-based method of dose calculation was adopted without adequate investigation of its ...